The memo, sent Friday, says similar measures have been implemented in other years and any decision must be made in consultation with the hospital's infection prevention and control team.
The biotech drug developer said Monday that it will pay $116.50 in cash for each share of Horizon, which makes a thyroid eye disease treatment that generated more than $1 billion in its first full year on the market.
With pharmacists in Ontario authorized to prescribe for minor ailments as of January 1, 2023, Ontario techs will be called upon to perform associated tasks.
While it is well known that emergency rooms have been crowded and struggling to cope, it's rare for managers to make such blunt statements of the problems in the province's hospitals.
